Management of multimorbidity and polypharmacy a huge challenge at all ages. Fabulous multidisciplinary workshop teeming with ideas and enthusiasm @livuniITM @Pharmaforkids @SedenKay@LivHPartners
Dan Kajungu's poster on community and health care workers ' attitudes to adverse drug event reporting. Plenty of work to be done! #EDCTPforum@GlobalPV_TGHN@SedenKay
"The impact of a 'no deal' #Brexit on the #NHS and medical research will be immediate" @martinmckee latest #BMJOpinion lays out the consequences of the ongoing political chaos around Brexit: https://t.co/8gzP38u0QJ
"There are more than 15 million people still living with HIV, not on treatment. 25% of those don’t know their status. We need to test more, treat more and deploy more prevention strategies. And scale up what we know is working." - President @BillClinton at #AIDS2018
“Academia is the alternative career path. Unless we adopt this view, we will continue to do untold damage to the mental health of some of our smartest people.” Senior research fellow Mark Humphries on post-PhD career paths https://t.co/i86iHzreiv
“Some of the greatest harms will not be measurable until it’s too late.” - @ppglobe's Senior Director Chloe Cooney discussing the impact of the #GlobalGagRule at this morning’s press conference. #AIDS2018
DolPHIN1 study shows pharmacokinetics of dolutegravir in breastfeeding mother infant pairs as well as superior virological response in the dolutegravir arm compared to efavirenz @UoLDolphin2#AIDS2018@DTHF_SA@UCT_Research